In addition to his 28 years as a practicing anesthesiologist and pain management specialist, Dr Hsu is a serial entrepreneur who has founded companies in the areas of medical devices and healthcare management software and consulting.
A drug development expert with 26 years of experience in pharmaceutical R&D, Peter has led or supported the development of six FDA-approved products and been involved in two major exits: Aragon to Janssen ($1B) and Saragon to Genetech-Roche ($1.75B)
A highly experienced patent litigator and former USPTO reviewer and attorney, Dr. Weinstein manages all aspects of intellectual property, transactions and corporate law. He also has significant pharma experience with support of two marketed products.
Gary has 23 years of clinical and corporate development experience with both large-cap and start-up pharmaceutical and medical device ventures, including marketing, in-licensing, strategic partnerships and M&A transactions.
Former FDA Director (CDER Division of Anesthesia, Analgesia and Addiction Products)
Former FDA Director (CDER Division of Gastroenterology Products Office of New Drugs)
Clinical pain specialist, key opinion leader and past president of the American Academy of Pain Medicine
Pharmaceutical and medical device corporate strategist, M&A and investment
Clinical toxicologist, strategist and marketing executive
Recognized authority and key opinion leader in drug metabolism, safety and disposition
Expert in formulation and combo drug development with extensive Pharma experience
Clinical anesthesiologist, assistant professor Harvard Medical School, Mass General
Business development expert with numerous pharmaceutical and medical device start-ups
Industry leader 505(b)(2) submissions to FDA with extensive opioid and analgesic experience
Industry leader in clinical assessments of respiratory safety and abuse deterrence of opioids
Worldwide leader in development and commercialization of pharmaceutical drug products
Copyright © 2022 Quivive Pharma, inc - All Rights Reserved.